AlphaYouCRSP: KASINGER JAMES R. discloses securities transactions
By AlphaYouPublished Form 4
KASINGER JAMES R.
Reporting filer
KASINGER JAMES R. reported Exercise or conversion in CRISPR Therapeutics AG: 10400 units of Common Shares, dated 2026-09-22. The full Form 4 contains 3 transaction entries.
- Disclosed
- Sep 24, 2026
Reported details
3 entries| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Shares | KASINGER JAMES R. | 2026-09-22 | M | Exercise or conversion | 10400 | 13.62 | 105,184 | 2 days | Filed terms
|
| Common Shares | KASINGER JAMES R. | 2026-09-22 | S | Sale | 10400 | 60.2365 | 94,784 | 2 days | Filed terms
|
| Stock Option (Right to Buy) (derivative) | KASINGER JAMES R. | 2026-09-22 | M | Exercise or conversion | 10400 | 0.00 | 83,232 | 2 days | Filed terms
|
Common Shares
- Owner
- KASINGER JAMES R.
- Date
- 2026-09-22
- Code
- M
- Action
- Exercise or conversion
- Quantity
- 10400
- Price
- 13.62
- Following holdings
- 105,184
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Common Shares
- transaction Date: 2026-09-22
- transaction Form Type: 4
- transaction Code: M
- equity Swap Involved: false
- transaction Shares: 10400
- transaction Price Per Share: 13.62
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 105184
- id: F1
- direct Or Indirect Ownership: D
Common Shares
- Owner
- KASINGER JAMES R.
- Date
- 2026-09-22
- Code
- S
- Action
- Sale
- Quantity
- 10400
- Price
- 60.2365
- Following holdings
- 94,784
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Common Shares
- transaction Date: 2026-09-22
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: false
- id: F2
- transaction Shares: 10400
- transaction Price Per Share: 60.2365
- id: F3
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 94784
- direct Or Indirect Ownership: D
Stock Option (Right to Buy) (derivative)
- Owner
- KASINGER JAMES R.
- Date
- 2026-09-22
- Code
- M
- Action
- Exercise or conversion
- Quantity
- 10400
- Price
- 0.00
- Following holdings
- 83,232
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Stock Option (Right to Buy)
- conversion Or Exercise Price: 13.62
- transaction Date: 2026-09-22
- transaction Form Type: 4
- transaction Code: M
- equity Swap Involved: false
- transaction Shares: 10400
- transaction Price Per Share: 0.00
- transaction Acquired Disposed Code: D
- id: F4
- expiration Date: 2027-05-31
- underlying Security Title: Common Shares
- underlying Security Shares: 10400
- shares Owned Following Transaction: 83232
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- KASINGER JAMES R.: General Counsel and Secretary.
- The filing reports a Rule 10b5-1 trading plan.
- F1: Includes 476 shares acquired under the CRISPR Therapeutics AG 2026 Employee Stock Purchase Plan.
- F2: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 6, 2026.
- F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.00 to $60.65, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- F4: This option was granted on May 31, 2017 with respect to 123,000 Common Shares of which 25% shall vest on May 31, 2018 and the remaining 75% shall vest monthly thereafter for 36 months.
Original sources
Prepared automatically from public filing data. Report a correction.